248 related articles for article (PubMed ID: 24187862)
1. Fuzhengpaidu granule regulates immune activation molecules CD38 and human leukocyte antigen-D related on CD4+ and CD8+ T cells in patients with acquired immunodeficiency syndrome/human immunodeficiency virus.
Jiang F; Zhang R; Gu Z; Zhang H; Guo H; Deng X; Liang J
J Tradit Chin Med; 2013 Aug; 33(4):439-43. PubMed ID: 24187862
[TBL] [Abstract][Full Text] [Related]
2. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
[TBL] [Abstract][Full Text] [Related]
3. [The correlation between HLA-DR or CD38 expression in CD8(+)T cells and CD4(+)T cells count in treatment-naive HIV/AIDS patients].
Xie J; Qiu Z; Han Y; Li Y; Song X; Li T
Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):36-9. PubMed ID: 26796651
[TBL] [Abstract][Full Text] [Related]
4. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
[TBL] [Abstract][Full Text] [Related]
5. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
Liu Z; Cumberland WG; Hultin LE; Prince HE; Detels R; Giorgi JV
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):83-92. PubMed ID: 9358102
[TBL] [Abstract][Full Text] [Related]
6. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.
de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A
Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984
[TBL] [Abstract][Full Text] [Related]
7. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
Li T; Qiu Z; Wang A; Sheng R
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921
[TBL] [Abstract][Full Text] [Related]
8. HCV coinfection does not alter the frequency of regulatory T cells or CD8+ T cell immune activation in chronically infected HIV+ Chinese subjects.
Zhuang Y; Wei X; Li Y; Zhao K; Zhang J; Kang W; Sun Y
AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1044-51. PubMed ID: 22214236
[TBL] [Abstract][Full Text] [Related]
9. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
[TBL] [Abstract][Full Text] [Related]
10. [Expression of CD38 and HLA-DR on CD8+ T cells in pediatric AIDS patients receiving highly active antiretroviral therapy (HAART)].
Jin CZ; Feng L; Xie TS; Wu LJ; Fang MX; Zhang FJ; Zhao Y; Wu NP
Zhonghua Er Ke Za Zhi; 2011 Jan; 49(1):49-52. PubMed ID: 21429312
[TBL] [Abstract][Full Text] [Related]
11. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study.
Giorgi JV; Liu Z; Hultin LE; Cumberland WG; Hennessey K; Detels R
J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):904-12. PubMed ID: 7686224
[TBL] [Abstract][Full Text] [Related]
13. Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls.
Lenkei R; Bratt G; Holmberg V; Muirhead K; Sandström E
Cytometry; 1998 Oct; 33(2):115-22. PubMed ID: 9773871
[TBL] [Abstract][Full Text] [Related]
14. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
Mahalingam M; Pozniak A; McManus TJ; Vergani D; Peakman M
Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
[TBL] [Abstract][Full Text] [Related]
15. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group.
Giorgi JV; Ho HN; Hirji K; Chou CC; Hultin LE; O'Rourke S; Park L; Margolick JB; Ferbas J; Phair JP
J Infect Dis; 1994 Oct; 170(4):775-81. PubMed ID: 7930717
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers.
Maes M; Bosmans E; Kubera M
Neuro Endocrinol Lett; 2015; 36(5):439-46. PubMed ID: 26707044
[TBL] [Abstract][Full Text] [Related]
17. Potential role for HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers.
Hua S; Lécuroux C; Sáez-Cirión A; Pancino G; Girault I; Versmisse P; Boufassa F; Taulera O; Sinet M; Lambotte O; Venet A
PLoS One; 2014; 9(7):e101920. PubMed ID: 25000587
[TBL] [Abstract][Full Text] [Related]
18. High background in ELISpot assays is associated with elevated levels of immune activation in HIV-1-seronegative individuals in Nairobi.
Liu AY; De Rosa SC; Guthrie BL; Choi RY; Kerubo-Bosire R; Richardson BA; Kiarie J; Farquhar C; Lohman-Payne B
Immun Inflamm Dis; 2018 Sep; 6(3):392-401. PubMed ID: 29974672
[TBL] [Abstract][Full Text] [Related]
19. Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach.
Karim R; Mack WJ; Stiller T; Operskalski E; Frederick T; Landay A; Young MA; Tien PC; Augenbraun M; Strickler HD; Kovacs A
AIDS; 2013 Jun; 27(9):1473-81. PubMed ID: 23945505
[TBL] [Abstract][Full Text] [Related]
20. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
